CELC
Celcuity Inc.
NASDAQ · Healthcare · Biotechnology · US
$80.61
−5.06%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 29.89x
- P/S forward
- 26.56x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -308.61x
- Price / sales
- —
- Price / cash flow
- -20.58x
Enterprise value
- Enterprise value
- $3.9B
- EV / sales
- —
- EV / EBITDA
- -21.29x
- EV / EBIT
- -18.90x
- Market cap
- $3.9B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026